688468.SHG Chemclin Diagnostics Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
5.80 CNY
Close of Nov 4, 2026
5.50 8.55
Market cap
CNY 2.33B
P/E
72.5x
P/B
1.61x
ROE
2.2%
Dividend yield
2.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688468.SHG undervalued?

Graham number
Price5.80
Graham value2.55
Premium127.5%

688468.SHG trades 127.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Chemclin Diagnostics Co. Ltd. A fundamental analysis

No fundamental analysis for Chemclin Diagnostics Co. Ltd. A yet.

Chemclin Diagnostics Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Chemclin Diagnostics Co. Ltd. A

Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sale of clinical immuno chemiluminescence diagnostic reagents and instruments in China. The company offers the LiCA series of diagnostic reagents, which is based on photo-induced chemiluminescence; the Chemclin series of diagnostic reagents and instruments, which is based on enzyme-catalyzed chemiluminescence; and routine clinical chemistry diagnostic reagents. Its products are used for the …

Full company profile